LEVAUR 250 (Levetiracetam Tablets 250 mg)

Manufacturer
Aurobindo Pharma Limited (Unit XV)(INDIA)

Registraction Number
MAL18056071AZ

Content:
LEVAUR 250 contains levetiracetam 250 mg per tablet.
Indications:

• Epilepsy: Treatment of partial-onset seizures in patients aged 1 month and older.
• Juvenile Myoclonic Epilepsy: Treatment of myoclonic seizures in patients aged 12 years and older.
• Idiopathic Generalized Epilepsy: Treatment of primary generalized tonic-clonic seizures in patients aged 12 years and older.

1. Dosage: The usual starting dose is 250 mg twice daily. The dose may be adjusted based on the patient's response and condition.
2. Consistency: Take the tablet at the same time each day.
3. Adherence: Do not miss doses, as this can increase the risk of seizures.
4. Monitoring: Regular monitoring of seizure frequency and side effects is recommended.